Trial intelligence / Profile preview

Marhame-Mafasel ointment versus diclofenac gel for knee osteoarthritis

IRCT20201126049498N2Phase 3Completed

Sponsor
Shahed University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Shahed University. Primary endpoints: Erythrocyte sedimentation rate, C-reactive protein and 7 more. Started Mar 2021; status: completed.

02

Drugs

diclofenac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20201126049498N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201126049498N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call